Stock BIEI PREMIER BIOMEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Premier Biomedical, Inc. Share Price

Equities

BIEI

US74048K2033

Specialty Chemicals

Delayed OTC Markets
Other stock markets
 12:44:36 02/05/2024 am IST 		5-day change 1st Jan Change
0.0013 USD +8.33% Intraday chart for Premier Biomedical, Inc. -7.14% +44.44%
07/03 Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology Officer CI
2022 Nova-Graphene Ballistics, Inc. Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology CI

Financials

Sales 2018 0.04 3.32 Sales 2019 0.01 1.19 Capitalization 78.42K 6.54M
Net income 2018 - 0 Net income 2019 - 0 EV / Sales 2018 1,61,49,039 x
Net Debt 2018 223K 18.59M Net Debt 2019 89.55K 7.47M EV / Sales 2019 1,17,62,132 x
P/E ratio 2018
-0.74 x
P/E ratio 2019
-0.06 x
Employees 4
Yield 2018 *
-
Yield 2019
-
Free-Float 99%
More Fundamentals * Assessed data

Chart Premier Biomedical, Inc.

Dynamic Chart

Latest news about Premier Biomedical, Inc.

Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology Officer CI
Nova-Graphene Ballistics, Inc. Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology CI
Itaú Unibanco S A : Brazilian billionaire Lemann leads initiative to build COVID-19 vaccine factory RE
William A. Hartman Resigns as Chief Executive Officer of Premier Biomedical, Inc CI
Heidi H. Carl Resigns as Chief Financial Officer of Premier Biomedical, Inc CI
Premier Biomedical, Inc. Announces Executive Changes CI
Premier Biomedical, Inc. Appoints David Caplan to the Board of Directors CI
Premier Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Premier Biomedical, Inc. Announces Resignation of Mitchell Felder as Chairman and Member of Board of Directors CI
Premier Biomedical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
Premier Biomedical, Inc. announced that it has received $0.025 million in funding from Green Coast Capital International S.A. CI
Premier Biomedical, Inc. announced that it expects to receive $5 million in funding from Green Coast Capital International S.A. CI
Premier Biomedical, Inc. announced that it has received $0.043 million in funding from PowerUp Lending Group, Ltd. CI
Premier Biomedical, Inc. announced that it expects to receive $0.043 million in funding from PowerUp Lending Group, Ltd. CI
Premier Biomedical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 CI
More news

Press releases Premier Biomedical, Inc.

Premier Graphene, Inc. (BIEI) Demonstrates Industry-Leading Innovations with Graphene-Enhanced Building Materials AQ
Premier Biomedical Inc. (BIEI), now known as Premier Graphene, Inc., engages Gustavo Carreño as Chief Technology Officer (CTO) AQ
Premier Biomedical Inc. (OTC: BIEI), Welcomes Officers, Directors and Key Advisors AQ
Premier Biomedical Inc. (OTC: BIEI), now known as Premier Graphene, Inc., specifies plans and timing for development of its Full Scale, Seed To Product Delivery, Graphene Initiative AQ
Nova Graphene Ballistics (OTC PINK: BIEI) Retains Award Winning Communication Firm To Expand Public Messaging AQ
More press releases

Quotes and Performance

1 day+8.33%
1 week-7.14%
Current month+30.00%
1 month+30.00%
3 months+18.18%
6 months+116.67%
Current year+44.44%
More quotes

Highs and lows

1 week
0.00
Extreme 0.001
0.00
1 month
0.00
Extreme 0.0008
0.00
Current year
0.00
Extreme 0.0008
0.00
1 year
0.00
Extreme 0.0005
0.00
3 years
0.00
Extreme 0.0005
0.01
5 years
0.00
Extreme 0.0002
0.04
10 years
0.00
Extreme 0.0002
147.50
More quotes

Managers and Directors - Premier Biomedical, Inc.

Managers TitleAgeSince
Gabe Vlad DFI
 Director of Finance/CFO - -
William Tynan AUD
 Comptroller/Controller/Auditor - -
Brain A. Lebrecht LAW
 General Counsel - -
More insiders

Quotes

Date Price Change Volume
01/24/01 0.0013 +8.33% 366,656
30/24/30 0.0012 -7.69% 5,209,994
29/24/29 0.0013 0.00% 335,000
26/24/26 0.0013 0.00% 48,032
25/24/25 0.0013 -7.14% 626,688

Delayed Quote OTC Markets, May 02, 2024 at 12:44 am IST

More quotes

Company Profile

Premier Graphene, Inc. is a global advanced materials firm with a focus on research, production and marketing of eco-friendly graphene. The Company’s graphene and novel additive formulations are integrated into the production process of other products. The Company is engaged in supplying large-scale industrial quantities. Its proprietary graphene blends and formulations target specific product enhancements sought by manufacturers.
Sector
Specialty Chemicals
More about the company

Sector Other Specialty Chemicals

1st Jan change Capi.
PREMIER BIOMEDICAL, INC. Stock Premier Biomedical, Inc.
+44.44% 1.43M
ECOLAB INC. Stock Ecolab Inc.
+13.72% 64.32B
SIKA AG Stock Sika AG
-3.80% 45.95B
GIVAUDAN SA Stock Givaudan SA
+13.69% 39.61B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+20.84% 25.74B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+8.66% 18.75B
CELANESE CORPORATION Stock Celanese Corporation
+0.61% 17.23B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.03% 15.86B
SYMRISE AG Stock Symrise AG
+0.81% 15.03B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-14.22% 13.99B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. BIEI Stock